Breast Cancer Screening Controversies

References

1. ↵
   Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129–34.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Olsen O, Gotzsche PC. Screening for breast cancer with mammography. The Cochrane Library, Issue 4, 2001. Oxford: Update Software.
3. ↵
   US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Available at http://www.ahcpr.gov/clinic/uspstfix.htm. Accessed February 2002.
4. ↵
   Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001; 164: 1837–46.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997; 47: 150–3.

   OpenUrlPubMedWeb of Science
6. ↵
   Manois LA. What is the contribution of CBE to breast cancer detection in a screening program [masters thesis]? Seattle: Seattle Pacific University, 1998.
7. ↵
   Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH. Predictors of sensitivity of clinical breast examination. Breast Cancer Res Treat 2002; 76: 73–81.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   National Center for Health Statistics Staff. Health, U. S. with urban and rural health chartbook, 2001. Hyattsville, Md: National Center for Health Statistics, 2001.
9. ↵
   Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101, 987 women without the disease. Lancet 2001; 358: 1389–99.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Reynolds T. Declining breast cancer mortality: what’s behind it? J Natl Cancer Inst 1999; 91: 750–3.

    OpenUrlFREE Full Text
11. ↵
    Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69: 349–55.
12. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 1985; 67: 65–74.
13. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988; 297: 943–8.
14. Tabar L, Gad A, Holmberg L, Ljungquist U. Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med 1985: 54158–64.
15. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening—preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49–56.

    OpenUrlCrossRefPubMedWeb of Science
16. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years—update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45: 263–70.

    OpenUrlCrossRefPubMedWeb of Science
17. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer 1997; 80: 2091–9.

    OpenUrlCrossRefPubMedWeb of Science
18. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994; 70: 542–8.

    OpenUrlCrossRefPubMedWeb of Science
19. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999; 353: 1903–8.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147: 1459–76.

    OpenUrlAbstract
21. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 1997; 22: 37–41.
22. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147: 1477–88.

    OpenUrlAbstract
23. ↵
    Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273: 149–54.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Larsson LG, Andersson I, Bjurstam N, et al. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40–49 at randomization. J Natl Cancer Inst Monogr 1997; 22: 57–61.
25. ↵
    Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in woman age 40 to 49 years. Ann Intern Med 2002; 137(5 Part 1): 305–12.
26. ↵
    Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 1993; 189: 661–3.

    OpenUrlPubMedWeb of Science
27. ↵
    Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997; 22: 63–7.
28. ↵
    Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? Lancet 2002; vol:pp. Available at: http://imae.thelancet.comn/extras/1093web.pdf.
29. ↵
    The frequency of breast cancer screening: results from the UKCCCR randomised trial. United Kingdom Co-ordinating Committee on Cancer Research. Eur J Cancer 2002; 38: 1458–64.
30. ↵
    Tabar L, Vitak B, Chen HT, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91: 1724–31.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338: 1089–96.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    Barton MB, Moore S, Polk S, Stalin E, Elmore JG, Fletcher SW. Increased patient concern after false-positive mammograms. J Gen Intern Med 2001; 16: 150–6.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    Pisano ED, Earp J, Schell M, Vokaty K, Denham A. Screening behavior of women after a false-positive mammogram. Radiology 1998; 208: 245–9.

    OpenUrlPubMedWeb of Science
34. ↵
    Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995; 87: 720–31.

    OpenUrlAbstract/FREE Full Text
35. ↵
    Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 1999; 282: 1270–80.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000; 92: 971–6.

    OpenUrlAbstract/FREE Full Text
37. ↵
    McPherson CP, Swenson KK, Jolitz G, Murray CL. Survival of women ages 40–49 years with breast carcinoma according to method of detection. Cancer 1997; 79: 1923–32.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    Thomas DB, Gao DL, Self SG, et al. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst 1997; 89: 355–65.

    OpenUrlFREE Full Text
39. ↵
    Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94: 1445–57.

    OpenUrlAbstract/FREE Full Text
40. ↵
    Semiglazov VF, Sagaidak VN, Moisyenko VM, Mikhailov EA. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer 1993; 29A: 2039–46.
41. ↵
    Holmberg L, Ekbom A, Calle E, Mokdad A, Byers T. Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450,000 women. Breast Cancer Res Treat 1997; 43: 137–40.

    OpenUrlCrossRefPubMedWeb of Science
42. ↵
    Newcomb PA, Weiss NS, Storer BE, Scholes D, Young BE, Voigt LF. Breast self-examination in relation to the occurrence of advanced breast cancer. J Natl Cancer Inst 1991; 83: 260–5.

    OpenUrlAbstract/FREE Full Text
43. ↵
    Harvey BJ, Miller AB, Baines CJ, Corey PN. Effect of breast self-examination techniques on the risk of death from breast cancer. CMAJ 1997; 157: 1205–12.

    OpenUrlAbstract/FREE Full Text
44. ↵
    Coates RJ, Uhler RJ, Brogan DJ, et al. Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States). Cancer Causes Control 2001; 12: 431–42.

    OpenUrlCrossRefPubMedWeb of Science
45. ↵
    Reeves MJ, Newcomb PA, Remington PL, Marcus PM. Determinants of breast cancer detection among Wisconsin (United States) women, 1988–90. Cancer Causes Control 1996: 7: 626–7.

    OpenUrlPubMed